
South & Central America Transfection Reagents and Equipment Market
No. of Pages: 108 | Report Code: BMIRE00030566 | Category: Life Sciences
No. of Pages: 108 | Report Code: BMIRE00030566 | Category: Life Sciences
The South & Central America transfection reagents and equipment market was valued at US$ 55.80 million in 2022 and is expected to reach US$ 99.22 million by 2030; it is estimated to register at a CAGR of 7.5% from 2022 to 2030. Growing Economic Burden of Cancer Fuels South & Central America Transfection Reagents and Equipment Market
According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, and it accounted for ~10 million deaths in 2020. As per the International Agency for Research on Cancer, the global cancer burden is likely to increase with the addition of 30.2 million more cases by 2040. According to the Breast Cancer Organization, approximately 5-10% of breast cancer cases worldwide are hereditary and are caused by abnormal genes passed from generations. According to the article "Lifestyle, Genetic Risk and Incidence of Cancer," published in the International Journal of Epidemiology in 2023, nearly 33% of cancer conditions that occur are hereditary, and the risk of genetic mutations is high in the disease. Hence, people are opting for genetic profiling for the early detection and personalized treatment of hereditary cancer cases. BRCA1 and BRCA2 are sometimes referred to as tumor suppressor genes. People who inherit the harmful variants of one of these genes are at a greater risk of several cancers, most notably breast and ovarian cancer, among other types. These people also tend to develop cancer at younger ages compared to people who do not have variations in the said genes. Studies focused on nucleic acid processing by cancer cells are likely to help understand cancer metabolism. DNA is typically packaged into a viral or non-viral particle to be transferred into the cell that is to be transfected. Gene transfer has been proposed as a new approach to enhance the effectiveness of antitumor drugs in treating intractable or metastatic cancers. The association of gene therapy and drugs (similar therapy) has been reported to strengthen the antiproliferative effects of classical treatments in lung, colorectal, pancreatic, bladder, and breast cancers, among others. Thus, the elevating economic burden of cancer bolsters the South & Central America transfection reagents and equipment market.South & Central America Transfection Reagents and Equipment Market Overview
South and Central America region is segmented into Brazil, Argentina, and Rest of South & Central America. Brazil hold more than half of the regional share in the year 2022.
Brazil has made significant developments in the pharmaceutical industry owing to its favorable economic policies and reforms, a solid hold in domestic pharmaceutical production, and elevated healthcare expenditure. As per the International Trade Administration (ITA), Brazil is the largest healthcare market in Latin America, and it spends 9.1% of its GDP on healthcare. Domestic companies dominate the total production of pharmaceutical products in the country, enabling its trade activities. As per the US Department of Commerce, domestic companies account for ~80% of the total count of pharmaceutical companies in Brazil. Thus, the growing pharmaceutical industry landscape is one of the major factors for Transfection reagents and equipment market growth in Brazil.
Furthermore, Argentina has the largest pharmaceutical industry in South & Central America, after Brazil. The transfection reagents and equipment market growth in the country is widely driven by extensive research and development efforts and growing domestic production of pharmaceuticals. The growing demand for pharmaceutical and biopharmaceutical products due to increasing uncertainties of health conditions, increasingly powerful regulatory environment for the pharmaceutical industry, and improving logistics of raw materials are likely to favor the growth of the transfection reagents and equipment market in Argentina during the forecast period.
Strategic insights for the South & Central America Transfection Reagents and Equipment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the South & Central America Transfection Reagents and Equipment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.South & Central America Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Transfection Reagents and Equipment Strategic Insights
South & Central America Transfection Reagents and Equipment Report Scope
Report Attribute
Details
Market size in 2022
US$ 55.80 Million
Market Size by 2030
US$ 99.22 Million
Global CAGR (2022 - 2030)
7.5%
Historical Data
2020-2021
Forecast period
2023-2030
Segments Covered
By Product
By Method
By End User
Regions and Countries Covered
South and Central America
Market leaders and key company profiles
South & Central America Transfection Reagents and Equipment Regional Insights
South & Central America Transfection Reagents and Equipment Market Segmentation
The South & Central America transfection reagents and equipment market is segmented based on product, method, application, end user, and country.
Based on product, the South & Central America transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.
In terms of method, the South & Central America transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is subcategorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.
By application, the South & Central America transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.
Based on end user, the South & Central America transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.
Based on country, the South & Central America transfection reagents and equipment market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America transfection reagents and equipment market in 2022.
Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, and MaxCyte Inc are some of the leading companies operating in the South & Central America transfection reagents and equipment market.
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
The South & Central America Transfection Reagents and Equipment Market is valued at US$ 55.80 Million in 2022, it is projected to reach US$ 99.22 Million by 2030.
As per our report South & Central America Transfection Reagents and Equipment Market, the market size is valued at US$ 55.80 Million in 2022, projecting it to reach US$ 99.22 Million by 2030. This translates to a CAGR of approximately 7.5% during the forecast period.
The South & Central America Transfection Reagents and Equipment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Transfection Reagents and Equipment Market report:
The South & Central America Transfection Reagents and Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Transfection Reagents and Equipment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Transfection Reagents and Equipment Market value chain can benefit from the information contained in a comprehensive market report.